Symbol
| TMEFF1
| contributors: mct - updated : 06-02-2024
|
HGNC name
| transmembrane protein with EGF-like and two follistatin-like domains 1
|
HGNC id
| 11866
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
lower levels of TMEFF1 expression in brain tumors than normal brain tissue | tumoral
|  
|  
| --over
|  
|
in ovarian cancer cells induced increased cellular proliferation, migration, and invasion but reduced apoptosis | tumoral
|  
|  
| --over
|  
|
of ANHAK and TMEFF1 in ovarian cancer indicated a higher degree of tumor malignancy and a worse prognosis | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | ovary | |
may be considered as a potential therapeutic target for ovarian cancer | cardiovascular | cardiomyopathy | | |
could be a therapeutic target to control the development of cardiac hypertrophy | cancer | reproductive | ovary | |
the interaction between AHNAK and TMEFF1 may become a potential anti-tumor target for ovarian cancer treatment |
| | | |
| plays a protective role in the modulation of adverse cardiac remodeling from pressure overload in mice | |
high Tgfb1 doses increased tomoregulin-1 (Tmeff1) levels, resulting in the repression of Bmp2 and bone formation in mice |